Amy Naylor

1 - 10 out of 31Page size: 10

Publications

  1. 2021
  2. Published

    Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids

    Adam Croft, Joana Campos, Amy Naylor, Angela Taylor, Myriam Chimen, Gareth Lavery, Karim Raza & Rowan Hardy, Feb 2021, In: Annals of the Rheumatic Diseases. 80, 2, p. 250-260 11 p.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Metabolic consequences for mice lacking endosialin: LC-MS/MS-based metabolic phenotyping of serum from C56Bl/6J control and CD248 knock-out mice

    Kieran Patrick, Matt Harrison, Gareth Lavery, Ed Rainger, Christopher Buckley & Amy Naylor, Feb 2021, In: Metabolomics. 17, 2, 14.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Adiponectin signalling in bone homeostasis, with age and in disease

    Amy Naylor & Helen McGettrick, 7 Jan 2021, In: Bone Research. 9, 1.

    Research output: Contribution to journal › Review article › peer-review

  5. 2019
  6. Published

    11β-HSD1 Plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy

    Craig Doig, Amy Naylor, Christopher Buckley, Gareth Lavery, Karim Raza & Rowan Hardy, 16 Aug 2019, In: Arthritis Research & Therapy. 21, 1, 188.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Distinct fibroblast subsets drive inflammation and damage in arthritis

    Adam Croft, Joana Campos, Jason Turner, Jennifer Marshall, Amy Naylor, Sam Kemble, Francesca Barone, Helen McGettrick & 4 others, , Andrew Filer & Christopher Buckley, 13 Jun 2019, In: Nature. 570, 7760, p. 246–251

    Research output: Contribution to journal › Article › peer-review

  8. 2018
  9. E-pub ahead of print

    Fibroblasts and Osteoblasts in Inflammation and Bone Damage

    Jason Turner, Amy Naylor, Christopher Buckley, Andrew Filer, 29 Aug 2018, Stromal Immunology. Owens, B. M. J. & Lakins, M. A. (eds.). Springer, Vol. 1060. p. 37-54 18 p. (Advances in Experimental Medicine and Biology).

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

  10. Published

    Endogenous Galectin-9 suppresses apoptosis in human rheumatoid arthritis synovial fibroblasts

    Amy Naylor, Simon Jones, Christopher Buckley, Andrew Filer & Janet Lord, 27 Aug 2018, In: Scientific Reports. 8, 8 p., 12887.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    11 beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis

    Rowan Hardy, Adam Croft, Amy Naylor, Guillaume Desanti, Christopher Buckley, Gareth Lavery & Karim Raza, Aug 2018, In: Journal of Autoimmunity. 92, p. 104-113 10 p.

    Research output: Contribution to journal › Article › peer-review

  12. 2017
  13. Published

    Multimerin-2 is a ligand for group14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface: MMRN2 binds three group 14 family C-type lectins

    Amy Naylor, Abdullah Khan, Peter Noy, Marco Mambretti, Aleksandra Korzystka, Christopher Buckley, Benjamin Willcox, Fiyaz Mohammed & Roy Bicknell, 2 Nov 2017, In: Oncogene. 36, p. 6097–6108

    Research output: Contribution to journal › Article › peer-review

  14. Published

    Detection and characterisation of bone destruction in murine rheumatoid arthritis using statistical shape models

    Ewan Ross, Guillaume Desanti, Atif Saghir, Andrew R. Clark, Christopher Buckley, Andrew Filer, Amy Naylor & Ela Claridge, Aug 2017, In: Medical Image Analysis. 40, p. 30-43

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 Next